VALIRX PLC
Advancing oncology & women's health therapeutics and offering preclinical research services.
VAL | IL
Overview
Corporate Details
- ISIN(s):
- GB00BLH13C52
- LEI:
- 213800VQKB9SJCQDET40
- Country:
- United Kingdom
- Address:
- STONEBRIDGE HOUSE, CM22 7BD HATFIELD HEATH
- Website:
- https://www.valirx.com/
- Sector:
- Mining and quarrying
- Industry:
- Mining of non-ferrous metal ores
Description
ValiRx PLC is a life science company dedicated to the early-stage development of therapeutics, with a primary focus on oncology and women's health. The company accelerates the translation of scientific discoveries into clinical applications by providing scientific, financial, and commercial expertise to progress its portfolio of drug candidates. Through its subsidiary, Inaphaea BioLabs, ValiRx also offers a suite of preclinical research services. The company's core strategy is to identify and advance innovative treatments for diseases with unmet medical needs, aiming to improve patient lives.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-11-13 15:30 |
Major Shareholding Notification
Holding(s) in Company
|
English | 21.0 KB | ||
| 2025-11-10 08:25 |
Major Shareholding Notification
Holding(s) in Company
|
English | 21.0 KB | ||
| 2025-11-04 18:30 |
Pre-Annual General Meeting Information
Posting of Circular and Notice of General Meeting
|
English | 41.5 KB | ||
| 2025-11-04 08:20 |
Share Issue/Capital Change
Result of WRAP Retail Offer
|
English | 25.2 KB | ||
| 2025-10-30 08:21 |
Share Issue/Capital Change
WRAP Retail Offer for up to £300,000
|
English | 34.2 KB | ||
| 2025-10-30 08:17 |
Share Issue/Capital Change
Fundraising of up to £1,050,000
|
English | 84.0 KB | ||
| 2025-10-14 08:00 |
Business and Financial Review
Inaphaea Commercial update
|
English | 21.7 KB | ||
| 2025-09-29 08:00 |
Interim Report
Half-year Report
|
English | 291.2 KB | ||
| 2025-09-18 08:00 |
Regulatory News Service
Inaphaea Commercial Update
|
English | 23.6 KB | ||
| 2025-08-26 08:00 |
Regulatory News Service
Commercial update
|
English | 17.7 KB | ||
| 2025-08-07 11:51 |
Regulatory News Service
ValiRx Awarded Grant from Open University
|
English | 16.2 KB | ||
| 2025-08-05 10:53 |
M&A Activity
Update on Evaluation Agreement with Stingray Bio
|
English | 17.9 KB | ||
| 2025-08-04 08:00 |
M&A Activity
Licensing Agreement with Dominion Biotech Ltd
|
English | 16.3 KB | ||
| 2025-07-29 08:00 |
M&A Activity
Collaboration Agreement with Voxcell BioInnovation
|
English | 17.2 KB | ||
| 2025-06-20 08:00 |
M&A Activity
Ambrose Exercise Option on VAL401
|
English | 16.9 KB |
Automate Your Workflow. Get a real-time feed of all VALIRX PLC filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for VALIRX PLC
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for VALIRX PLC via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
